Both bioinformatics and experiment suggest that miR-30b-5p could also downregulate the expression of Ca2+/calmodulin-dependent protein kinase II (CaMKII), and restoration of its function inhibits cardiac hypertrophy [32]. The gene discussed is CAMK2G; the disease is cardiac hypertrophy.